Cosmax, Inc. (KRX:192820)

Market Cap	1.86T -14.8%
Revenue (ttm)	2.49T +11.9%
Net Income	156.51B +109.5%
EPS	13,792.47 +109.5%
Shares Out	11.35M
PE Ratio	11.90
Forward PE	13.54
Dividend	3,300.00 (1.99%)
Ex-Dividend Date	Mar 30, 2026

Volume	45,028
Open	168,800
Previous Close	165,800
Day's Range	160,000 - 170,800
52-Week Range	155,200 - 287,000
Beta	0.75
Analysts	Buy
Price Target	241,416.67 (+50.23%)
Earnings Date	Aug 11, 2026

About Cosmax

Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, and skin fabric names; and make up under the Xfine, JellTeX, ARTCOTTA, Bi-Coat, creamline, Thixolash, and CRYSTAL PRISM brands; oriental medicine under...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1992
• Employees: 1,535
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 192820

Financial Performance

In 2025, Cosmax's revenue was 2.40 trillion, an increase of 10.74% compared to the previous year's 2.17 trillion. Earnings were 123.06 billion, an increase of 43.44%.

Analyst Summary

According to 24 analysts, the average rating for 192820 stock is "Buy." The 12-month stock price target is ₩241,417, which is an increase of 50.23% from the latest price.

Price Target

₩241,417

(50.23% upside)

Analyst Consensus: Buy